Antibiotic choice for respiratory infection in pediatric
Keywords:
antibiotic, respiratory tract infection, pediatric, hypersensitivity reactionAbstract
Respiratory infection (RTI) is one of the leading factors of death in children in India. In most countries, RTI is a common cause of hospitalisation in children under five years old. There are different guidelines for management of various type of RTI. Most of these, emphasis on use of antibiotics in specific sub type of RTI. While literatures recommend avoiding antibiotic in viral infections, they mostly suggest beta lactams as first line drugs. Depends on patients, amoxicillin remains drug of choice for most of out-patients. In case of hypersensitivity to penicillin, cephalosporin commonly will be substituent. If specific and atypical organism found, need to switch to other type such as macrolides. In this research, we aimed to briefly review current guidelines and literatures regarding antibiotic selection in paediatrics suffering from different type of respiratory tract infection.
Downloads
References
Selvaraj K, Chinnakali P, Majumdar A, Krishnan IS. Acute respiratory infections among under-5 children in India: A situational analysis. J Nat Sci Biol Med 2014;5:15-20
Biezen, R., Brijnath, B., Grando, D. et al. Management of respiratory tract infections in young children—A qualitative study of primary care providers’ perspectives. npj Prim Care Resp Med 27, 15 (2017).
Baumann P, Fuchs A, Gotta V, Ritz N, Baer G, Bonhoeffer JM, et al. (2022) The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections. PLoS ONE 17(3): e0264305.
Florin TA, Byczkowski T, Gerber JS, Ruddy R, Kuppermann N. Diagnostic Testing and Antibiotic Use in Young Children With Community-Acquired Pneumonia in the United States, 2008–2015. J Pediatric Infect Dis Soc. 2020; 9(2):248–52.
Thomas M, Bomar PA. Upper Respiratory Tract Infection. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532961/
Kumar SG, Majumdar A, Kumar V, Naik BN, Selvaraj K, Balajee K. Prevalence of acute respiratory infection among under-fi ve children in urban and rural areas of puducherry, India. J Nat Sc Biol Med 2015;6:3-6.
Dasaraju PV, Liu C. Infections of the Respiratory System. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996.Chapter 93. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8142.
Centre of Disease Control and Prevention, Respiratory infections, Yellow book, chapter 8, Available at https://www.cdc.gov/travel/yellowbook/2020/posttravel-evaluation/respiratory-infections/
Centre of Disease Control and Prevention, Pediatric Outpatient Treatment Recommendations, Available at https://www.cdc.gov/antibiotic-use/clinicians/pediatric-treatment-rec.html#ref1
Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, Nelson CE, Rosenfeld RM, Shaikh N, Smith MJ, Williams PV, Weinberg ST; American Academy of Pediatrics. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013 Jul;132(1):e262-80.
Hersh AL, Jackson MA, Hicks LA; American Academy of Pediatrics Committee on Infectious Diseases. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013 Dec;132(6):1146-54.
Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults external icon. Am Fam Physician. 2012;86(2):153-9.
Ralston SL, Lieberthal AS, Meissner HC, et al. American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitisexternal icon. Pediatrics. 2014 Nov;134(5):e1474-502.
Blomgren K, Alho OP, Ertama L, Huovinen P, Korppi M, et al.(2005) Acute sinusitis: Finnish clinical practice guidelines. Scand J Infect Dis 37: 245.
Esposito S, Principi N (2008) Guidelines for the diagnosis and treatment of acute and subacute rhinosinusitis in children. J Antimicrob Chemoth 20: 147–157.
Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJC, et al. (2012) IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 54: e72–e112.
Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, et al. (2013) Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics 132: e262–e280.
Schu¨nemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, et al. (2007) WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. WHO. Lancet Infect Dis 7: 21–31.
Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, Pankey GA, Seleznick M, Volturo G, Wald ER, File TM Jr; Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 Apr;54(8):e72-e112. doi: 10.1093/cid/cir1043. Epub 2012 Mar 20. PMID: 22438350.
Bradley JS, Byington CL, Shah SS, et al; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-e76.
Ginsburg A-S,Mvalo T, Nkwopara E, et al. Amoxicillin for 3 or 5 Days for chest-indrawing pneumonia in Malawian children. N Engl J Med. 2020;383(1):13-23.
Rubino C, Polak M, Schröpf S, Münch H, Smits A, Cossey V,et al,. Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients. The Pediatric Infectious Disease Journal: November 2021 - Volume 40 - Issue 11 - p 997-1003.
Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011 Oct; 53(7):e25-76. doi: 10.1093/cid/cir531. Epub 2011 Aug 31. PMID: 21880587; PMCID: PMC7107838.
Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries. Geneva: World Health Organization; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK264162/
Geppe NA, Blokhin BM, Shamsheva OV, Abdrakhmanova ST, Alikhanova KA, Myrzabekova GT. Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial. Can Respir J. 2021 Nov 15;2021:5570178.
Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, Sturgeon K, Finn A, et al, Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. JAMA. 2021 Nov 2;326(17):1713-1724.
Amoxicillin, (electronic version), IBM Watson Health information, Available at https://www.micromedexsolutions.com/ 10/10/2022
Bhattacharya S. The facts about penicillin allergy: a review. J Adv Pharm Technol Res. 2010;1(1):11-17.
Norton AE, Konvinse K, Phillips EJ, Broyles AD. Antibiotic Allergy in Pediatrics. Pediatrics. 2018 May;141(5):e20172497.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
